AllianceBernstein’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,454
Closed -$273K 3334
2024
Q1
$273K Buy
6,454
+1,120
+21% +$47.2K ﹤0.01% 2836
2023
Q4
$223K Buy
+5,334
New +$197K ﹤0.01% 2948
2017
Q4
Sell
-6,558
Closed -$739K 3086
2017
Q3
$739K Sell
6,558
-7,980
-55% -$868K ﹤0.01% 2436
2017
Q2
$1.63M Buy
14,538
+1,144
+9% +$129K ﹤0.01% 1994
2017
Q1
$1.56M Buy
13,394
+4,222
+46% +$467K ﹤0.01% 1977
2016
Q4
$966K Buy
9,172
+3,787
+70% +$397K ﹤0.01% 2275
2016
Q3
$595K Buy
5,385
+195
+4% +$25.8K ﹤0.01% 2469
2016
Q2
$756K Sell
5,190
-60,801
-92% -$8.62M ﹤0.01% 2363
2016
Q1
$9.45M Buy
65,991
+36,010
+120% +$5.11M 0.01% 867
2015
Q4
$4.63M Buy
29,981
+2,421
+9% +$353K ﹤0.01% 1090
2015
Q3
$3.94M Hold
27,560
﹤0.01% 1171
2015
Q2
$3.96M Hold
27,560
﹤0.01% 1241
2015
Q1
$3.89M Buy
27,560
+6,670
+32% +$1.03M ﹤0.01% 1258
2014
Q4
$3.1M Buy
20,890
+14,730
+239% +$2.16M ﹤0.01% 1417
2014
Q3
$948K Buy
+6,160
New +$927K ﹤0.01% 2230
2014
Q2
Sell
-59
Closed -$7K 3669
2014
Q1
$7K Buy
59
+39
+195% +$4.25K ﹤0.01% 3313
2013
Q4
$2K Hold
20
﹤0.01% 3258
2013
Q3
$2K Buy
+20
New +$1.3K ﹤0.01% 3278

Other funds holding TARO

AllianceBernstein's TARO Position: Q2 2024 in Review

AllianceBernstein sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2024, closing a stake of 6,454 shares — an estimated $273K sold.

AllianceBernstein first reported a position in TARO in Q3 2013 and held it in 18 quarters. The position peaked at $9.45M in Q1 2016. 16 funds tracked by Wall St. Rank hold TARO as of Q2 2024.

  • AllianceBernstein reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2024 after selling out during the quarter.
  • AllianceBernstein sold 6,454 Taro Pharmaceutical Industries Ltd. shares in Q2 2024, an estimated $273K.
  • AllianceBernstein first reported a position in Taro Pharmaceutical Industries Ltd. in Q3 2013 and held it in 18 quarters.
  • AllianceBernstein's Taro Pharmaceutical Industries Ltd. position peaked at $9.45M in Q1 2016.
  • 16 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2024.

Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.